EUVIMEDEUVIMED entdecken
Leserbrief

Ceramides and renal dysfunction in coronary artery disease: Promising biomarkers awaiting validation

Muhammet Cihat Çelik, Mücahit Aker, Macit Kalçık

Journal of Clinical Lipidology · 2026-02 · 20 (2) · 467-468

DOI: 10.1016/j.jacl.2025.09.019 ↗

Kurz gefasst

Leserbrief in der Zeitschrift Journal of Clinical Lipidology, 2026-02. Verfasst von Muhammet Cihat Çelik und 2 weiteren Autor:innen. Beteiligte Einrichtung: Department of Cardiology, Hitit University Erol Olçok Education and Research Hospital, Corum, Turkey (Drs Çelik and Aker). Die Arbeit nennt 5 Literaturangaben.

AbstractBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Kein Abstract verfügbar.

Autor:innen und Institutionen

  • Department of Cardiology, Hitit University Erol Olçok Education and Research Hospital, Corum, Turkey (Drs Çelik and Aker).
  • Faculty of Medicine, Department of Cardiology, Hitit University, Corum, Turkey (Dr Kalçık). Electronic address: macitkalcik@yahoo.com.

Zitieren

APA

Çelik, M. C., Aker, M., & Kalçık, M. (2026). Ceramides and renal dysfunction in coronary artery disease: Promising biomarkers awaiting validation. Journal of Clinical Lipidology, 20(2), 467-468. https://doi.org/10.1016/j.jacl.2025.09.019

Vancouver

Çelik MC, Aker M, Kalçık M. Ceramides and renal dysfunction in coronary artery disease: Promising biomarkers awaiting validation. Journal of Clinical Lipidology. 2026;20(2):467-468. doi:10.1016/j.jacl.2025.09.019

BibTeX
@article{elik2026,
  author = {Çelik, Muhammet Cihat and Aker, Mücahit and Kalçık, Macit},
  title = {Ceramides and renal dysfunction in coronary artery disease: Promising biomarkers awaiting validation},
  journal = {Journal of Clinical Lipidology},
  year = {2026},
  volume = {20},
  number = {2},
  pages = {467--468},
  doi = {10.1016/j.jacl.2025.09.019}
}
Kostenlos starten →